Subramanyam Janardhan Tantry

This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Inipharm, Inc., Jubilant Epicore LLC. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subramanyam Janardhan Tantry. Retrieved from https://idiyas.com/inventor/subramanyam-janardhan-tantry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Yeshwanthpur Bangalore, IN (2022)
Bengaluru, IN (2023)

Company Filing History:

Years Active: 2022-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12774278 - Thiazole HSD17B13 inhibitors and uses thereof (2026-10-27),

2. 12673930 - Thiophene HSD17B13 inhibitors and uses thereof (2026-07-07),

3. 12643858 - HSD17B13 inhibitors and uses thereof (2026-06-02),

4. 12617772 - Hydroxypyridine HSD17B13 inhibitors and uses thereof (2026-05-05),

5. 12479797 - Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors (2025-11-25),

6. 12227489 - Dichlorophenol HSD17B13 inhibitors and uses thereof (2025-02-18),

7. 11827619 - Dichlorophenol HSD17B13 inhibitors and uses thereof (2023-11-28),

8. 11352322 - Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors (2022-06-07),

Title: Subramanyam Janardhan Tantry: Innovator in Pharmaceutical Research

Introduction

Subramanyam Janardhan Tantry is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments for liver and metabolic diseases. With a total of three patents to his name, Tantry's work is paving the way for advancements in medical therapies.

Latest Patents

Tantry's latest patents include the development of Dichlorophenol HSD17B13 inhibitors and their pharmaceutical compositions. These inhibitors are described as useful for treating liver diseases, metabolic disorders, and cardiovascular diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). The significance of these inventions lies in their potential to improve patient outcomes in serious health conditions.

Career Highlights

Throughout his career, Tantry has worked with reputable companies such as Inipharm, Inc. and Jubilant Epicore LLC. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Tantry's notable coworkers include Sampath Kumar Anandan and Joshua Odingo. Their collaborative efforts have further enhanced the impact of his research and innovations.

Conclusion

Subramanyam Janardhan Tantry is a distinguished inventor whose work in pharmaceutical research is making a significant difference in the treatment of liver and metabolic diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.